BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ingredientpharm - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ingredientpharm
X-ORIGINAL-URL:https://ingredientpharm.com
X-WR-CALDESC:Events for Ingredientpharm
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261020
DTEND;VALUE=DATE:20261022
DTSTAMP:20260415T100856
CREATED:20260112T144129Z
LAST-MODIFIED:20260112T144129Z
UID:2218-1792454400-1792627199@ingredientpharm.com
SUMMARY:World Vaccine Congress Europe 2026
DESCRIPTION:The World Vaccine Congress Europe 2026 is a premier global event focused on vaccines\, immunotherapy\, and infectious disease research in Europe. Importantly\, it convenes leaders from pharmaceuticals\, biotechnology\, academia\, regulators\, and public health organizations. Together\, they share knowledge\, explore innovations\, and discuss strategies for vaccine development\, manufacturing\, and distribution. As a result\, the congress is recognized as one of the world’s leading vaccine-focused events. Consequently\, it serves as a strategic platform for scientific exchange\, collaboration\, and business development. \nIn 2026\, the congress will address key topics shaping the vaccine landscape. Specifically\, these include novel technologies\, mRNA and viral vector platforms\, adjuvants\, and immuno-oncology vaccines. In addition\, sessions will cover clinical development strategies\, regulatory frameworks\, pandemic preparedness\, and large-scale manufacturing solutions. Furthermore\, discussions will explore global health initiatives\, AI-driven research\, advanced analytics\, and supply-chain resilience. Overall\, these themes highlight the intersection of innovation\, policy\, and practical vaccine delivery. \nTypically\, attendees include vaccine developers\, pharmaceutical and biotech executives\, and clinical researchers. Moreover\, immunologists\, regulatory experts\, policy leaders\, public health officials\, and investors are well represented. As a result\, participants can network\, form collaborations\, and gain insights into emerging trends and regulatory expectations. Notably\, these insights span both European and global markets. \nFinally\, the congress offers strong opportunities to showcase technologies and explore partnership or licensing opportunities. Additionally\, companies gain direct access to key decision-makers across the vaccine ecosystem. Key industries represented include biotechnology\, pharmaceutical manufacturing\, CROs\, diagnostics\, and public health organizations. By uniting the full stakeholder spectrum\, the 2026 congress aims to accelerate innovation and strengthen global vaccination strategies.
URL:https://ingredientpharm.com/event/world-vaccine-congress-europe-2026/
LOCATION:Amsterdam RAI\, Europaplein 24\, Amsterdam\, 1078 GZ\, Netherlands
CATEGORIES:pharmaceutical
ATTACH;FMTTYPE=image/jpeg:https://ingredientpharm.com/wp-content/uploads/2025/11/World-Vaccine-Congress-Europe-2026.jpg
ORGANIZER;CN="Terrapinn Holdings Ltd":MAILTO:enquiry.uk@terrapinn.com
END:VEVENT
END:VCALENDAR